Kestra Medical Technologies Announces Upsized Public Offering of $138M.

Kestra Medical Technologies has priced a primary public offering of 6 million common shares at $23 each, raising $138 million in gross proceeds. The offering is expected to close on December 4, with a 30-day option to purchase an additional 900,000 shares. BofA Securities, Piper Sandler, J.P. Morgan, Goldman Sachs & Co. LLC, and Wells Fargo Securities are acting as bookrunners. A final prospectus will be filed with the SEC.